Featured Event Transfiere 2023 Málaga España Del 15/02/2023 to 17/02/2023 Healthcare Agrifood Industrial biotechnology International AseBio will play a leading role in Transfiere 2023 with talks and a stand next month in Malaga to showcase the work of...
Featured Event Apply to the first edition of AseBio-Merck Award "Advanced Therapies Startup Competition" Madrid España Del 12/09/2022 to 05/10/2022 Healthcare Advanced therapies ¡Deadline extended! You can apply until October 5th
Featured Event Biotech Communications 101 Seminar - Consilium & AseBio Investor Day On-line Del 26/04/2022 15:00 to 26/04/2022 16:00 Healthcare Communication In the framework of the AseBio Investor Day 2022 that we are holding next Thursday 28th April, our partners have the...
Featured Event The Annual 2022 Two-Day IVD Conference Madrid España Del 24/03/2022 to 25/03/2022 Healthcare
The Ministry of Economy, Trade and Business announces a $200 million investment fund to bo... 15/04/2026 Healthcare Access to innovation International Financing The announcement was made during the Spain–United States Business Meeting held in Boston, organized by ICEX España... AseBio
GENESIS Biomed leads the European PHEMS Business Hackathon in Barcelona to shape the fut... 09/04/2026 Healthcare Access to innovation The event brought together experts from hospitals, research organizations, industry and innovation ecosystems to co... Partners - GENESIS Biomed
U.S. announces pharmaceutical tariffs under Section 232: what it means for biotech compani... 10/04/2026 Healthcare Drug discovery Rare diseases Innovative drugs Industrial biotechnology International At AseBio, we believe this Executive Order creates uncertainty for the European biotechnology sector—especially for... AseBio
Biobide obtains two ENAC GLP certifications and expands its capacity to conduct studies fo... 07/04/2026 Healthcare Climate change Agrifood Industrial biotechnology International Corporate Biobide, a subsidiary of Biotechnology Assets (BME Growth: BST), has obtained two Good Laboratory Practice (GLP)... Partners - Biotechnology Assets
BCN HEALTH publishes a systematic review highlighting the substantial economic burden of h... 01/04/2026 Healthcare Access to innovation BCN HEALTH has published the study “Economic burden of heart failure in Europe: A systematic review of costs and cost... Partners - BCN Health
Ysios Capital launches InceptionBio, a €100M fund to drive biotech company creation 27/03/2026 Healthcare Drug discovery InceptionBio is a new €100 million target-size fund focused on biotech company creation and early-stage projects, with a... Partners - Ysios Capital Partners
